(Q46968421)

English

Serum lipid profiles in patients receiving endocrine treatment for breast cancer--the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial

scientific article published in October 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

Serum lipid profiles in patients receiving endocrine treatment for breast cancer--the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

author name string

L W C Chow

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

C W L Cheng

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

J L N Wong

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

M Toi

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

Biomedicine and Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

59 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

S302-5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

Anti-aromatase agents in the treatment and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib: a specific COX-2 inhibitor with anticancer properties

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal receptor determination of 1,052 Chinese breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal antiinflammatory drugs and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine and clinical endpoints of exemestane as neoadjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0753-3322(05)80051-4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16507398

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46968421&oldid=2140149669"